Ecron AcuNova has appointed Dr A S Arvind as the strategic advisor. He will guide the company on operational excellence and will mentor the team.
From his immense experience, Arvind will support the clients medically, scientifically and strategically in their clinical development plan. Prior to EA, Dr Arvind was chief operating officer of Clinigene, CRO and a Biocon subsidiary. Joining Biocon in 2000, he played an integral role in development of Biocon’s pipeline and contributed to its strategic alliances with global majors. He was also the Consultant Physician with West Wales General Hospital, and has held prestigious positions at UK hospitals. He worked as medical director and consultant gastroenterologist at Mallya Hospital, Bangalore.
Dr Arvind obtained MBA from the University of Birmingham, FRCP from the Royal Colleges of Physicians, London & Glasgow and MD from Bangalore Medical College.
According to D A Prasanna, chairman & managing director, Manipal Acunova, Dr Arvind brings in a wealth of experience in drug development and in areas of diabetes & biosimilars. His success in getting marketing authorization for Biocon, successful US FDA audit of sites and relationship with investigators will make a difference to our customers.